Robust, Scalable Analytics to Develop Digital Biomarkers

Clinical ink offers a best-in-class analytics platform to support the development and evaluation of digital biomarkers in clinical trials. Our multidisciplinary team of scientists, architects, data engineers, data scientists, and software engineers are using this highly collaborative analytics platform to drive innovation forward.

Robust, Scalable Analytics to Develop Digital Biomarkers

Clinical ink has developed a best-in-class analytics platform to support the development and evaluation of digital biomarkers in clinical trials. Our multidisciplinary team of scientists, architects, data engineers, data scientists, and software engineers are using this highly collaborative analytics platform to drive innovation forward.

Together, we have achieved success in implementing solutions throughout the engineering pipeline.

An Analysis Platform for the Digital Frontier of Research

An Analysis Platform for the Digital Frontier of Research

Validate and Deliver Data in Real-Time

  • Validate measurements derived from sensors, algorithms, and clinical data
  • Fuse data sources from multiple sensors into a common reference frame
  • Ingest data into enterprise data lake solutions for external partner delivery
  • Conduct real-time quality control checks on incoming data sources
Woman looking at screen up close

Ensure Better Patient Engagement

  • Apply methods to improve patient engagement and compliance
  • Visualize data-monitoring dashboards to track patient adherence, data quality
  • Perform root cause analyses to understand patient behavior in bring your own device (BYOD) studies
  • Build machine learning solutions to improve patient-centric insights into behavior and compliance

Develop Disease-Specific Digital Biomarkers

  • Evaluate sensor data streams to identify optimal solutions for capturing disease-relevant signals
  • Engineer features using time- and frequency-dependent signal processing routines and algorithms
  • Construct multivariate modeling methods to evaluate mixed effects in complex study designs
Two scientists anylising digital biomarkers on a big screen

The future growth of Sponsors and researchers incorporating Digital Health Technologies (DHTs), or sensors and wearables, into their clinical trials will depend on ensuring the highest standards of data collection, transmission, security, quality, and analysis for optimal digital biomarkers. Scalable analytics platforms are essential to implementing and reinforcing these data standards.

Enable patient science via mobile assessments engineered by experienced clinical, software, data, and user experience experts. Power patient outcomes with Clinical ink.

Innovate, Analyze, and Develop with Confidence

The title page of the Clinical ink study “Digital Biomarkers as Endpoints in Parkinson’s Disease” with another page from the study below.

White Paper

Data, technology and patient science converge as Clinical ink develops digital biomarkers for Parkinson’s Disease

Learn more

Title page of parkinson's disease case study with another page from the study underneath

Case Study

Clinical ink translates data from sensors and wearables into digital biomarkers in the WATCH-PD Study

Download

The Digital Frontier of Parkison’s Research:

Webinar

Dr. Josh Cosman of AbbVie and Dr. David Anderson of Clinical ink discuss digital biomarkers and the digital frontier of Parkinson’s research

Watch the Webinar

Blog

Sensor fusion reveals a fuller picture of the patient and enables the development of digital biomarkers

Read more

Explore Our Digital Biomarkers Analysis Platform

Want to learn more?

Set up time with our experts to see the Clinical ink digital biomarkers analysis platform in action.

Complete the form below to schedule a demo with our experts

Power patients to empower clinical discovery.

Scroll to Top